Skip to main content
Signal8

Welch Stephen Andrew

SEC insider (Form 3/4/5 filer). CIK 0001944355. EVP & Head of Spec Generics at Mallinckrodt plc (NONE). 4 reported Form 4/5 transactions since Sep 2024; latest on Nov 10, 2025. Located in HAZELWOOD, MO.

Companies Welch Stephen Andrew has filed insider reports for

  • Mallinckrodt plc (NONE): Officer, EVP & Head of Spec Generics
Welch Stephen Andrew profile photo

Welch Stephen Andrew

CIK: 0001944355

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mallinckrodt plc logo
NONE

Mallinckrodt plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • No ticker

    Keenova Therapeutics plc

    Nov 10, 2025
    Disposition

    Restricted Stock Units

    Direct
    43.8K shares-
  • No ticker

    Mallinckrodt plc

    Jul 31, 2025
    Award

    Restricted Stock Units

    Direct
    32.8K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Exercise
    Direct
    5.5K shares-
  • Mallinckrodt plc logo
    No ticker

    Mallinckrodt plc

    Jan 1, 2025
    Tax Payment
    Direct
    1.8K shares-

1-4 of 4